CEO Brainard, along with experts, discuss positive final results in the Phase 2 Posoleucel Multi-Virus Prevention Study as presented at the recently held 64th ASH Annual Meeting on an investor webcast to be held on December 14 at 4:30 pm. Webcast Link
Published first on TheFly
